NCT01761578View on ClinicalTrials.gov

ARTDIVA Study : First in Man Safety Evaluation of the ART18Z Bioresorbable Stent

NACompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

June 30, 2012

Primary Completion Date

June 30, 2013

Conditions
Coronary Artery Disease
Interventions
DEVICE

ART18Z Bioresorbable stent

The drug free fully bioresorbable coronary stent ART18Z is a balloon expandable poly lactic acid stent.

Trial Locations (5)

Unknown

Polyclinique les Fleurs, Ollioules

Hôpital Européen Georges Pompidou, Paris

Hôpital Haut Leveque, Pessac

Clinique Pasteur, Toulouse

Hôpital Rangueil, Toulouse

Sponsors
All Listed Sponsors
lead

Arterial Remodeling Technologies

INDUSTRY

NCT01761578 - ARTDIVA Study : First in Man Safety Evaluation of the ART18Z Bioresorbable Stent | Biotech Hunter | Biotech Hunter